0001474064-12-000015.txt : 20120201 0001474064-12-000015.hdr.sgml : 20120201 20120201160919 ACCESSION NUMBER: 0001474064-12-000015 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20120130 FILED AS OF DATE: 20120201 DATE AS OF CHANGE: 20120201 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: STRATEMEIER ED CENTRAL INDEX KEY: 0001474064 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-23272 FILM NUMBER: 12562729 MAIL ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: NPS PHARMACEUTICALS INC CENTRAL INDEX KEY: 0000890465 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 870439579 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 BUSINESS PHONE: (908) 450-5300 MAIL ADDRESS: STREET 1: 550 HILLS DRIVE CITY: BEDMINSTER STATE: NJ ZIP: 07921 4 1 edgar.xml PRIMARY DOCUMENT X0304 4 2012-01-30 0000890465 NPS PHARMACEUTICALS INC NPSP 0001474064 STRATEMEIER ED 550 HILLS DRIVE BEDMINSTER NJ 07921 0 1 0 0 SVP & General Counsel Stock Options 3.34 2012-01-30 4 A 0 18000 0 A 2020-02-19 Common Stock 18000 18000 D On February 19, 2010, the Reporting Person was granted options to purchase shares of Common Stock under the Issuer's 2005 Omnibus Incentive Plan, which are subject to both performance conditions and time-based vesting. On January 30, 2012, the performance criteria for 18,000 of these options had been satisfied because the Issuer's NDA was accepted by the FDA. These 18,000 options will vest and become exercisable based on the following vesting schedule: 25% on each of the first four anniversaries of the date of grant. Edward Stratemeier 2012-02-01